InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

29
Insider
Date
Role
Action
Shares
Price
Amount
Jessica Newcomb
2 Nov 2026
Principal Accounting Officer
Sold on a plan
1,460
$22.98
$33.55K
Jessica Newcomb
2 Nov 2026
Principal Accounting Officer
Sold on a plan
5,571
$22.28
$124.11K
Adam Crystal
2 Nov 2026
President, R&D
Sold after exercise
1,100
$22.99
$25.29K
Adam Crystal
2 Nov 2026
President, R&D
Sold after exercise
3,900
$22.26
$86.82K
Adam Crystal
1 Oct 2026
President, R&D
Sold after exercise
600
$25.32
$15.19K
Adam Crystal
1 Oct 2026
President, R&D
Sold after exercise
26,400
$24.45
$645.60K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
2,400
$25.17
$60.41K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
5,100
$23.97
$122.24K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
700
$22.80
$15.96K
Adam Crystal
1 Sep 2026
President, R&D
Sold after exercise
27,000
$22.37
$603.91K
Adam Crystal
3 Aug 2026
President, R&D
Sold after exercise
21,733
$27.35
$594.42K
Adam Crystal
3 Aug 2026
President, R&D
Sold after exercise
5,267
$26.79
$141.10K
Adam Crystal
1 Jul 2026
President, R&D
Sold after exercise
7,371
$30.25
$222.95K
Adam Crystal
1 Jul 2026
President, R&D
Sold after exercise
19,629
$29.34
$575.96K
Adam Crystal
1 Jun 2026
President, R&D
Sold after exercise
20,860
$23.06
$480.94K
Adam Crystal
1 Jun 2026
President, R&D
Sold after exercise
6,140
$22.25
$136.63K
Adam Crystal
1 May 2026
President, R&D
Sold after exercise
1,100
$22.00
$24.20K
Adam Crystal
1 May 2026
President, R&D
Sold after exercise
25,900
$21.19
$548.90K
Adam Crystal
15 Apr 2026
President, R&D
Sold after exercise
38,460
$25.00
$961.50K
Adam Crystal
1 Apr 2026
President, R&D
Sold after exercise
27,000
$21.20
$572.48K
Adam Crystal
25 Mar 2026
President, R&D
Sold after exercise
12,000
$20.11
$241.32K
Adam Crystal
5 Mar 2026
President, R&D
Sold on a plan
20,251
$15.00
$303.77K
Adam Crystal
25 Feb 2026
President, R&D
Sold on a plan
54,345
$12.77
$694.21K
Adam Crystal
3 Feb 2026
President, R&D
Sell
201
$12.90
$2.59K
Adam Crystal
3 Feb 2026
President, R&D
Sell
18,251
$12.26
$223.71K
Barbara Weber
3 Feb 2026
Director, Executive Chair
Sell
333
$12.90
$4.29K
Barbara Weber
3 Feb 2026
Director, Executive Chair
Sell
30,186
$12.26
$370.00K
Daniella Beckman
3 Feb 2026
Chief Financial Officer
Sell
113
$12.90
$1.46K
Daniella Beckman
3 Feb 2026
Chief Financial Officer
Sell
10,204
$12.26
$125.07K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 16
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 804,382
History held since 10 Sep 2020